A single-centre comparison of the clinical outcomes at 6 months of renal transplant recipients administered Adoport® or Prograf ® preparations of tacrolimus

Clinical Kidney Journal

Volumn 6, Issue 1, 2013, Pages 21-28

  Connor, Andrew ^a   Prowse, Andrew ^a   Newell, Paul ^b   Rowe, Peter A ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Adoport; Prograf; renal transplant; tacrolimus

Indexed keywords

ADOPORT; ALEMTUZUMAB; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; VALGANCICLOVIR;

ADULT; AGED; ARTICLE; CYTOMEGALOVIRUS INFECTION; DELAYED GRAFT FUNCTION; DRUG BLOOD LEVEL; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84873341832     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfs154     Document Type: Article

References (24)

1. Sandoz® UK. Adoport Summary of Product Characteristics. http://www.medicines.org.uk/emc/medicine/23205/SPC/ adoport%200. 5%20mg%20capsules,%20hard/ (12 December 2011, date last accessed)
2. Medicines Evaluation Board in the Netherlands, 2010. Tacrolimus Public Assessment Report of the Medicines Evaluation Board in the Netherlands. db.cbg-meb.nl/mri/par/nlh-1342- 001-002-003.pdf (12 December 2011, date last accessed)
3. Harrison JJ, Schiff JR, Coursol CJ et al. Generic immunosuppression in solid organ transplantation: a Canadian perspective. Transplantation 2012; 93: 657-665
4. Guleria S, Kamboj M, Chatterjee A et al. Generic tacrolimus (Pan Graf ) in renal transplantation: an experience of 155 recipients in India. Transplant Proc 2008; 40: 2237-2239
5. Kim SJ, Huh KH, Han DJ et al. A 6-month, multicenter, single-arm pilot study to evaluate the efficacy and safety of generic tacrolimus (TacroBell) after primary renal transplantation. Transplant Proc 2009; 41: 1671-1674
6. Muller H, Solari S, Zuniga C et al. Immunosuppression with generic tacrolimus and mycophenolate mofetil in renal transplant recipients: preliminary report in Chile. Transplant Proc 2008; 40: 705-707
7. Holm A, Hernandez M. A post-hoc analysis of the safety and efficacy of tacrolimus (Prograf ) versus a 'generic formulation' of tacrolimus (tenacrine) as primary immunosuppressive therapy in LRD and CAD, adults and pediatric renal transplant recipients. Transplantation 2008; 86(2S): abstract 528
8. ClinicalTrials.Gov: NCT01120028. Open-label, Randomised Multicentre Study of CAMPATH-1H Versus Basiliximab Induction Treatment and Sirolimus Versus Tacrolimus Maintenance Treatment for the Preservation of Renal Function in Patients Receiving Kidney Transplants. http://clinicaltrials.gov/ct2/ show/NCT01120028 (18 December 2011, date last accessed)
9. Yarlagadda SG, Coca SG, Garg AX et al. Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant 2008; 23: 2995-3003
10. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753-760
11. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999; 130: 461-470
12. R Development Core Team. R Project: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2012. ISBN 3-900051-07-0, http://www.R-project.org/
13. Terry Therneau. A Package for Survival Analysis in S. R package version 2.36-12, 2012
14. Krejčí K, Tichý T, Al-Gabri S et al. Protocol biopsy of a transplanted kidney as a tool for monitoring adequacy of immunosuppressive therapy: 10 years of experience from a single transplant center. Transplant Proc 2011; 43: 1576-1582
15. Luan FL, Kommareddi M, Ojo AO. Impact of cytomegalovirus disease in D+/R- kidney transplant patients receiving 6 months low-dose valganciclovir prophylaxis. Am J Transplant 2011; 11: 1936-1942
16. Sollinger HW, Sundberg AK, Leverson G et al. Mycophenolate mofetil versus enteric-coated mycophenolate sodium: a large, single-center comparison of dose adjustments and outcomes in kidney transplant recipients. Transplantation 2010; 89: 446-451
17. Aptaramanov B, Seyahi N, Alagoz S et al. A comparison of mycophenolate mofetil with mycophenolate sodium in renal transplant recipients on tacrolimus-based treatment. Transplant Proc 2011; 43: 833-836
18. Ciancio G, Gaynor JJ, Zarak A et al. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplantation with tacrolimus and steroid avoidance: four-year analysis. Transplantation 2011; 91: 1198-1205
19. MHRA, 2010. Oral tacrolimus products: measures to reduce risk of medication errors. MHRA Drug Saf Update 2010; 3: 5
20. Venkatamaranan R, Fontes P, DeVera M et al. Generic substitution of tacrolimus appears to be safe in the short term in clinically stable solid organ transplant patients, but monitoring of tacrolimus blood concentration in individual patient is essential. In: Poster presented at the American Transplant Congress (ATC). San Diego, USA, 2010 (Abstract 1741)
21. McDevitt-Potter LM, Sadaka B, Tichy EM et al. A multicenter experience with generic tacrolimus conversion. Transplantation 2011; 92: 653-657
22. Abdulnour HA, Araya CE, Dharnidharka VR. Comparison of generic tacrolimus and Prograf drug levels in a pediatric kidney transplant program: brief communication. Pediatr Transplant 2010; 14: 1007-1011
23. Alloway RR, Sadaka B, Trofe-Clark J et al. A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipients. Am J Transplant 2012;12:2825-2831
24. Connor A, Prowse A, MacPhee I et al. Generic tacrolimus in renal transplantation: trough blood concentration as a surrogate for drug exposure. Transplantation 2012; 93: e45-e46